CN1764455A - 包含大环内酯免疫调节剂的药用组合物 - Google Patents

包含大环内酯免疫调节剂的药用组合物 Download PDF

Info

Publication number
CN1764455A
CN1764455A CNA2004800080903A CN200480008090A CN1764455A CN 1764455 A CN1764455 A CN 1764455A CN A2004800080903 A CNA2004800080903 A CN A2004800080903A CN 200480008090 A CN200480008090 A CN 200480008090A CN 1764455 A CN1764455 A CN 1764455A
Authority
CN
China
Prior art keywords
ceramide
macrolide
immunosuppressant
compositions
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800080903A
Other languages
English (en)
Chinese (zh)
Inventor
M·格拉斯贝格尔
S·希尔施
F·K·迈尔
N·塞卡特
A·施蒂茨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of CN1764455A publication Critical patent/CN1764455A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNA2004800080903A 2003-04-04 2004-04-02 包含大环内酯免疫调节剂的药用组合物 Pending CN1764455A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307867.2A GB0307867D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition
GB0307867.2 2003-04-04

Publications (1)

Publication Number Publication Date
CN1764455A true CN1764455A (zh) 2006-04-26

Family

ID=9956230

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800080903A Pending CN1764455A (zh) 2003-04-04 2004-04-02 包含大环内酯免疫调节剂的药用组合物

Country Status (12)

Country Link
US (2) US20070021377A1 (https=)
EP (1) EP1638558A2 (https=)
JP (1) JP2006522060A (https=)
CN (1) CN1764455A (https=)
BR (1) BRPI0409169A (https=)
CA (1) CA2519958A1 (https=)
GB (1) GB0307867D0 (https=)
IS (1) IS8103A (https=)
MX (1) MXPA05010704A (https=)
NO (1) NO20055170L (https=)
RS (1) RS20050723A (https=)
WO (1) WO2004087202A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118903092A (zh) * 2024-07-30 2024-11-08 中山大学 亚油酸在制备提高革兰氏阳性菌对抗生素敏感性药物中的应用

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2885491B1 (fr) * 2005-05-16 2020-03-06 Nutricos Technologies Traitement de la secheresse keratinique par des glycerides
DE102007052380A1 (de) * 2007-10-31 2009-05-07 Bitop Ag Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9221220D0 (en) * 1992-10-09 1992-11-25 Sandoz Ag Organic componds
FR2710527B1 (fr) * 1993-09-30 1995-12-08 Roussel Uclaf Nouvelles compositions cosmétiques et dermatologiques associant céramides et acide linoléique, leur préparation.
JPH08133979A (ja) * 1994-09-16 1996-05-28 Sando Yakuhin Kk 局所適用薬剤組成物
ATE299017T1 (de) * 1994-10-26 2005-07-15 Novartis Pharma Gmbh Arzneimittel
DE19544507B4 (de) * 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
DK1064942T3 (da) * 1998-03-26 2004-11-01 Fujisawa Pharmaceutical Co Sustained release-fremstilling af et makrolid
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
GB0125443D0 (en) * 2001-10-23 2001-12-12 Novartis Ag Organic Compounds
GB0200429D0 (en) * 2002-01-09 2002-02-27 Novartis Ag Organic compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118903092A (zh) * 2024-07-30 2024-11-08 中山大学 亚油酸在制备提高革兰氏阳性菌对抗生素敏感性药物中的应用

Also Published As

Publication number Publication date
BRPI0409169A (pt) 2006-04-11
CA2519958A1 (en) 2004-10-14
AU2004226822A1 (en) 2004-10-14
NO20055170D0 (no) 2005-11-03
GB0307867D0 (en) 2003-05-14
WO2004087202A2 (en) 2004-10-14
RS20050723A (sr) 2007-11-15
JP2006522060A (ja) 2006-09-28
NO20055170L (no) 2006-01-04
EP1638558A2 (en) 2006-03-29
WO2004087202A3 (en) 2005-02-03
US20070021377A1 (en) 2007-01-25
US20080132534A1 (en) 2008-06-05
MXPA05010704A (es) 2005-12-12
IS8103A (is) 2005-10-31

Similar Documents

Publication Publication Date Title
CN1767826A (zh) 包括免疫抑制剂的用于治疗皮肤疾病的药物组合物
EP1255564B1 (en) Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator
US20080132534A1 (en) Pharmaceutical composition comprising a macrolide immunomodulator
CN1771036A (zh) 用于治疗皮肤病学疾病的大环内酯和局部麻醉剂的组合
AU2004226822B2 (en) Pharmaceutical composition comprising a macrolide immunomodulator
CN1761470A (zh) 用于治疗皮肤病或炎性肠病的大环内酯t－细胞免疫调节剂和钙化醇的组合
CN1764444A (zh) 大环内酯t－细胞调节剂或免疫抑制剂与类视色素的协同组合
CN1771035A (zh) 包含大环内酯类t－细胞免疫调节剂或免疫抑制剂和抗菌剂的组合物
HK1052633B (en) Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20060426